These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10611318)

  • 1. Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes.
    Glick A; Popescu N; Alexander V; Ueno H; Bottinger E; Yuspa SH
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14949-54. PubMed ID: 10611318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
    Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes.
    Game SM; Huelsen A; Patel V; Donnelly M; Yeudall WA; Stone A; Fusenig NE; Prime SS
    Int J Cancer; 1992 Sep; 52(3):461-70. PubMed ID: 1328069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
    J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.
    Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A
    Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratinocyte growth inhibition by high-dose epidermal growth factor is mediated by transforming growth factor beta autoinduction: a negative feedback mechanism for keratinocyte growth.
    Yamasaki K; Toriu N; Hanakawa Y; Shirakata Y; Sayama K; Takayanagi A; Ohtsubo M; Gamou S; Shimizu N; Fujii M; Miyazono K; Hashimoto K
    J Invest Dermatol; 2003 Jun; 120(6):1030-7. PubMed ID: 12787131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TGF-beta co-receptor endoglin modulates the expression and transforming potential of H-Ras.
    Santibanez JF; Pérez-Gómez E; Fernandez-L A; Garrido-Martin EM; Carnero A; Malumbres M; Vary CP; Quintanilla M; Bernabéu C
    Carcinogenesis; 2010 Dec; 31(12):2145-54. PubMed ID: 20884686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model.
    Vijayachandra K; Lee J; Glick AB
    Cancer Res; 2003 Jul; 63(13):3447-52. PubMed ID: 12839923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcriptional regulatory function of p53 is essential for suppression of mouse skin carcinogenesis and can be dissociated from effects on TGF-beta-mediated growth regulation.
    Ponnamperuma RM; King KE; Elsir T; Glick AB; Wahl GM; Nister M; Weinberg WC
    J Pathol; 2009 Oct; 219(2):263-74. PubMed ID: 19718706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development.
    Amendt C; Schirmacher P; Weber H; Blessing M
    Oncogene; 1998 Jul; 17(1):25-34. PubMed ID: 9671311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cripto-1 alters keratinocyte differentiation via blockade of transforming growth factor-beta1 signaling: role in skin carcinogenesis.
    Shukla A; Ho Y; Liu X; Ryscavage A; Glick AB
    Mol Cancer Res; 2008 Mar; 6(3):509-16. PubMed ID: 18337457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-β enhances invasion and metastasis in Ras-transfected human malignant epidermal keratinocytes.
    Davies M; Prime SS; Eveson JW; Price N; Ganapathy A; D'Mello A; Paterson IC
    Int J Exp Pathol; 2012 Apr; 93(2):148-56. PubMed ID: 22414291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
    Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
    Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic Ki-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factor-beta receptor III.
    Yan Z; Deng X; Friedman E
    J Biol Chem; 2001 Jan; 276(2):1555-63. PubMed ID: 11029459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K; Sheng H; Shao J; Beauchamp RD
    Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.
    Han G; Lu SL; Li AG; He W; Corless CL; Kulesz-Martin M; Wang XJ
    J Clin Invest; 2005 Jul; 115(7):1714-23. PubMed ID: 15937546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.
    Fanayan S; Firth SM; Butt AJ; Baxter RC
    J Biol Chem; 2000 Dec; 275(50):39146-51. PubMed ID: 10993898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma.
    Glick AB; Lee MM; Darwiche N; Kulkarni AB; Karlsson S; Yuspa SH
    Genes Dev; 1994 Oct; 8(20):2429-40. PubMed ID: 7958907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.